Vanguard Capital Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.23B Sell
83,752,662
-64,073
-0.1% -$5.65M 0.15% 105
2026
Q2
$6.56B Buy
83,816,735
+482,902
+0.6% +$39M 0.14% 112
2026
Q1
$7.22B Buy
+83,333,833
New +$7.98B 0.18% 96

Other funds holding MDT

Vanguard Capital Management's MDT Position: Q3 2026 in Review

Vanguard Capital Management reduced its Medtronic (MDT) stake by 0.08% in Q3 2026, selling an estimated $5.65M and leaving 83,752,662 shares worth $7.23B. The position accounts for 0.15% of the portfolio, ranked #105.

Vanguard Capital Management first reported a position in MDT in Q1 2026 and has held it in 3 quarters since. 2,206 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Vanguard Capital Management held 83,752,662 shares of Medtronic worth $7.23B as of Q3 2026.
  • Vanguard Capital Management sold 64,073 Medtronic shares in Q3 2026, an estimated $5.65M.
  • Medtronic made up 0.15% of Vanguard Capital Management's portfolio in Q3 2026, its #105 holding.
  • Vanguard Capital Management first reported a position in Medtronic in Q1 2026 and has held it in 3 quarters since.
  • 2,206 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.